We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New AI-Based Method Improves Diagnosis of Drug-Resistant Infections

By LabMedica International staff writers
Posted on 09 Apr 2025

Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. More...

These infections are more difficult to treat, often necessitate costlier or more toxic medications, and lead to extended hospital stays and higher mortality rates. In 2021, the World Health Organization (WHO) reported that 450,000 people developed multidrug-resistant tuberculosis, with a treatment success rate falling to just 57%. Current resistance detection methods, employed by organizations such as the WHO, either take too long—such as culture-based testing—or fail to detect rare mutations, as seen with some DNA-based tests. Now, a new artificial intelligence (AI)-based method has been developed to more accurately detect genetic markers of antibiotic resistance in Mycobacterium tuberculosis and Staphylococcus aureus, which could facilitate faster and more effective treatment.

Researchers at Tulane University (New Orleans, LA, USA) have introduced an innovative Group Association Model (GAM), leveraging machine learning to identify genetic mutations associated with drug resistance. Unlike traditional tools that might mistakenly link unrelated mutations to resistance, GAM operates without relying on prior knowledge of resistance mechanisms, making it more adaptable and capable of identifying previously undetected genetic alterations. The model, detailed in Nature Communications, addresses both the slow diagnostic processes and the failure to detect rare mutations by analyzing whole genome sequences. It compares groups of bacterial strains with varying resistance profiles to identify genetic changes that consistently indicate resistance to specific drugs.

In their study, the researchers applied GAM to over 7,000 strains of Mtb and nearly 4,000 strains of S. aureus, identifying crucial mutations linked to resistance. They discovered that GAM not only matched or surpassed the accuracy of the WHO’s resistance database but also significantly reduced false positives, which are incorrect markers of resistance that could lead to improper treatment. The combination of machine learning with GAM also enhanced its predictive capabilities, particularly when working with limited or incomplete data. In validation tests using clinical samples from China, the machine-learning-enhanced model outperformed the WHO-based methods in predicting resistance to critical first-line antibiotics. This breakthrough is important because early detection of resistance allows doctors to adjust treatment regimens appropriately, preventing the infection from worsening or spreading. The model's ability to identify resistance without requiring expert-defined rules also suggests it could be applied to other bacterial infections.

“Current genetic tests might wrongly classify bacteria as resistant, affecting patient care,” said lead author Julian Saliba, a graduate student in the Tulane University Center for Cellular and Molecular Diagnostics. “Our method provides a clearer picture of which mutations actually cause resistance, reducing misdiagnoses and unnecessary changes to treatment.”


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
STI Test
REALQUALITY RQ-SevenSTI
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.